2019 Press Releases
February 15, 2019
American Diabetes Association® Names Three Awardees for $4.875 Million in 2019 Pathway to Stop Diabetes Research Grants
The American Diabetes Association announced today it is awarding this year’s prestigious Pathway to Stop Diabetes grants, totaling $4.875 million dollars, to three researchers, with each scientist receiving $1.625 million dollars over a five-year grant term to support breakthroughs in basic science, clinical science, technology, care and potential cures in the field of diabetes.
January 15, 2019
Three ADA Pathway Grant Awardees’ Collaborative Breakthrough: Analysis Describing the Genetic Link Between Beta (β) Cell Function and Type 2 Diabetes Published in Cell Reports
American Diabetes Association (ADA) Pathway to Stop Diabetes® grant recipients Michael L. Stitzel, PhD, of the Jackson Laboratory, Stephen C.J. Parker, PhD, of the University of Michigan, and Praveen Sethupathy, PhD, of Cornell University, recently embarked on a collaborative research initiative empowered by the ADA Pathway to Stop Diabetes program. Bringing together diverse areas of expertise, their collaboration led to today’s report that establishes new detail about the genetic signatures of the cells that produce and release insulin, pancreatic beta (β) cells.
January 9, 2019
House Votes to Defend Health Care Law in Federal Appeals Court
Today the U.S. House of Representatives voted to petition to intervene in a case before the U.S. Court of Appeals for the Fifth Circuit that could determine the future of the Affordable Care Act (ACA). The House will ask to join 17 attorneys general in the appeal of a December District Court ruling that found the entire ACA invalid because Congress eliminated the individual mandate penalty in its 2017 tax reform bill.
January 8, 2019
American Diabetes Association® Welcomes 2019 Principal Officers and New Members to National Board of Directors
The American Diabetes Association (ADA) is honored to welcome the 2019 Principal Officers and Board of Directors. The 18-member board is comprised of forward-thinking medical, scientific, education and executive professionals, who will strategically lead and focus efforts to ensure the ADA continues to be synonymous with excellence.